These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25976094)

  • 1. Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis.
    Sternak M; Jakubowski A; Czarnowska E; Slominska EM; Smolenski RT; Szafarz M; Walczak M; Sitek B; Wojcik T; Jasztal A; Kaminski K; Chlopicki S
    Int Immunopharmacol; 2015 Sep; 28(1):105-14. PubMed ID: 25976094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse.
    Sternak M; Khomich TI; Jakubowski A; Szafarz M; Szczepański W; Białas M; Stojak M; Szymura-Oleksiak J; Chłopicki S
    Pharmacol Rep; 2010; 62(3):483-93. PubMed ID: 20631412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
    Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S
    Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6.
    Chłopicki S; Kurdziel M; Sternak M; Szafarz M; Szymura-Oleksiak J; Kamiński K; Żołądź JA
    Pharmacol Rep; 2012; 64(2):369-76. PubMed ID: 22661188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
    Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
    Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis.
    Mateuszuk Ł; Khomich TI; Słomińska E; Gajda M; Wójcik L; Łomnicka M; Gwóźdź P; Chłopicki S
    Pharmacol Rep; 2009; 61(1):76-85. PubMed ID: 19307695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis.
    Kremer M; Hines IN; Milton RJ; Wheeler MD
    Hepatology; 2006 Jul; 44(1):216-27. PubMed ID: 16799967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism.
    Nicoletti F; Di Marco R; Zaccone P; Salvaggio A; Magro G; Bendtzen K; Meroni P
    Hepatology; 2000 Oct; 32(4 Pt 1):728-33. PubMed ID: 11003616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis.
    Arshad MI; Rauch M; L'helgoualc'h A; Julia V; Leite-de-Moraes MC; Lucas-Clerc C; Piquet-Pellorce C; Samson M
    Eur J Immunol; 2011 Aug; 41(8):2341-8. PubMed ID: 21557213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis.
    Lamacchia C; Rodriguez E; Palmer G; Vesin C; Seemayer CA; Rubbia-Brandt L; Gabay C
    Eur J Immunol; 2012 May; 42(5):1294-303. PubMed ID: 22539301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Methylnicotinamide ameliorates lipotoxicity-induced oxidative stress and cell death in kidney proximal tubular cells.
    Tanaka Y; Kume S; Araki H; Nakazawa J; Chin-Kanasaki M; Araki S; Nakagawa F; Koya D; Haneda M; Maegawa H; Uzu T
    Free Radic Biol Med; 2015 Dec; 89():831-41. PubMed ID: 26482866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoma-derived growth factor participates in concanavalin A-induced hepatitis.
    Wang EM; Hu TH; Huang CC; Chang YC; Yang SM; Huang ST; Wu JC; Ma YL; Chan HH; Liu LF; Lu WB; Kung ML; Wen ZH; Wang JC; Ko CY; Tsai WL; Chu TH; Tai MH
    FASEB J; 2020 Dec; 34(12):16163-16178. PubMed ID: 33063394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periplocoside A, a pregnane glycoside from Periploca sepium Bge, prevents concanavalin A-induced mice hepatitis through inhibiting NKT-derived inflammatory cytokine productions.
    Wan J; Zhu YN; Feng JQ; Chen HJ; Zhang RJ; Ni J; Chen ZH; Hou LF; Liu QF; Zhang J; Yang L; Tang W; Yang YF; Nan FJ; Zhao WM; Zuo JP
    Int Immunopharmacol; 2008 Sep; 8(9):1248-56. PubMed ID: 18602071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD36 deficiency attenuates immune-mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10.
    Xu C; Zhang C; Ji J; Wang C; Yang J; Geng B; Zhao T; Zhou H; Mu X; Pan J; Hu S; Lv Y; Chen X; Wen H; You Q
    Hepatology; 2018 May; 67(5):1943-1955. PubMed ID: 29220536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective effect of intrasplenic transplantation of Ad-IL-18BP/IL-4 gene-modified fetal hepatocytes on ConA-induced hepatitis in mice.
    Shao X; Qian Y; Xu C; Hong B; Xu W; Shen L; Jin C; Wu Z; Tong X; Yao H
    PLoS One; 2013; 8(3):e58836. PubMed ID: 23516562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alleviation of fatty liver in a rat model by enhancing N
    Takeuchi K; Yokouchi C; Goto H; Umehara K; Yamada H; Ishii Y
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):203-210. PubMed ID: 30446221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate (EGCG) attenuates concanavalin A-induced hepatic injury in mice.
    Liu D; Zhang X; Jiang L; Guo Y; Zheng C
    Acta Histochem; 2014 May; 116(4):654-62. PubMed ID: 24373695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide 3-kinase δ/γ inhibition does not prevent concanavalin A-induced hepatitis.
    Liu Y; Xiong L; Chang Y; Tang J; Ang W; Yang T; Pi W; Yang X; Ye W; Luo Y; Wang Z
    Mol Med Rep; 2013 Nov; 8(5):1305-10. PubMed ID: 23969545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-39 exacerbates concanavalin A-induced liver injury.
    Li Y; Gong L; Weng L; Pan X; Liu C; Li M
    Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):94-99. PubMed ID: 33412981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice.
    Tagawa Y; Matthys P; Heremans H; Dillen C; Zaman Z; Iwakura Y; Billiau A
    J Leukoc Biol; 2000 Jan; 67(1):90-6. PubMed ID: 10648002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.